Crossmark

Hypoxia and glucose metabolism assessed by FMISO and FDG PET for predicting IDH1 mutation and 1p/19q codeletion status in newly diagnosed malignant gliomas

Crossref DOI link: https://doi.org/10.1186/s13550-021-00806-6

Published Online: 2021-07-21

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Suzuki, Kenta

Kawai, Nobuyuki http://orcid.org/0000-0002-3293-6917
Ogawa, Tomoya

Miyake, Keisuke

Shinomiya, Aya

Yamamoto, Yuka

Nishiyama, Yoshihiro

Tamiya, Takashi
Funding

Funding for this research was provided by:

KAKENHI (C: 19k09483)
License Information

Text and Data Mining valid from 2021-07-21

Version of Record valid from 2021-07-21
More Information

Article History

Received: 18 May 2021

Accepted: 24 June 2021

First Online: 21 July 2021

Declarations

:

: All procedures involving human participants were performed in accordance with the ethical standards of the institutional research committee of Kagawa University Faculty of Medicine and in accordance with the principles of the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below